C Morimoto

1.0k total citations
16 papers, 930 citations indexed

About

C Morimoto is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, C Morimoto has authored 16 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in C Morimoto's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). C Morimoto is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). C Morimoto collaborates with scholars based in United States, Japan and Canada. C Morimoto's co-authors include S F Schlossman, S F Schlossman, Stuart F. Schlossman, Tomohiko Matsuyama, Jonathan Kay, Shuji Akiyama, Akira Yamada, Nam H. Dang, Kenneth M. Yamada and Yoshihiro Torimoto and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Clinical & Experimental Immunology.

In The Last Decade

C Morimoto

15 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Morimoto United States 12 489 294 289 249 142 16 930
Patrice Hermann Japan 14 881 1.8× 133 0.5× 122 0.4× 181 0.7× 78 0.5× 17 1.2k
Gina Leytze United States 11 834 1.7× 142 0.5× 234 0.8× 202 0.8× 133 0.9× 11 1.1k
M A Ursa Spain 6 394 0.8× 380 1.3× 103 0.4× 230 0.9× 138 1.0× 6 780
Christi L. Wood United States 8 580 1.2× 214 0.7× 443 1.5× 235 0.9× 64 0.5× 10 1.1k
Margit C. Szabo United States 9 824 1.7× 737 2.5× 283 1.0× 262 1.1× 188 1.3× 10 1.3k
Carmela Kantor Finland 11 230 0.5× 383 1.3× 219 0.8× 410 1.6× 197 1.4× 14 891
Carol Doss United States 8 406 0.8× 241 0.8× 106 0.4× 289 1.2× 276 1.9× 8 811
Inka Scheffrahn Germany 13 149 0.3× 117 0.4× 344 1.2× 351 1.4× 272 1.9× 13 821
Jeff Bradshaw United States 5 986 2.0× 70 0.2× 385 1.3× 193 0.8× 73 0.5× 5 1.3k
Alain Vallé France 8 941 1.9× 156 0.5× 153 0.5× 289 1.2× 300 2.1× 8 1.2k

Countries citing papers authored by C Morimoto

Since Specialization
Citations

This map shows the geographic impact of C Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Morimoto more than expected).

Fields of papers citing papers by C Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Morimoto. The network helps show where C Morimoto may publish in the future.

Co-authorship network of co-authors of C Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of C Morimoto. A scholar is included among the top collaborators of C Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Morimoto. C Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Kobayashi, Hiroshi, Osamu Hosono, Satoshi Iwata, et al.. (2004). The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation. Clinical & Experimental Immunology. 137(1). 101–108. 33 indexed citations
3.
Kobata, T & C Morimoto. (1999). [T cell receptor and its related molecules in signal transduction].. PubMed. 57(2). 273–7. 1 indexed citations
4.
Abe, Masaki, Sachiko Yano, Kenji Kitamura, et al.. (1998). Surrogate thrombopoietin. Immunology Letters. 61(2-3). 73–78. 4 indexed citations
5.
Dong, Runyu, Kouichi Tachibana, Martin Hegen, et al.. (1997). Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. The Journal of Immunology. 159(12). 6070–6076. 98 indexed citations
6.
Jacquot, Serge, T Kobata, S. Iwata, C Morimoto, & S F Schlossman. (1997). CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. The Journal of Immunology. 159(6). 2652–2657. 108 indexed citations
7.
Wu, Mei X., Z. Ao, Martin Hegen, C Morimoto, & S F Schlossman. (1996). Requirement of Fas(CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. The Journal of Immunology. 157(2). 707–713. 32 indexed citations
8.
Dong, Rui & C Morimoto. (1996). Role of CD26 for CD4 memory T cell function and activation.. PubMed. 9(3). 153–62. 15 indexed citations
9.
Agematsu, Kazunaga, T Kobata, K Sugita, et al.. (1994). Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27.. The Journal of Immunology. 153(4). 1421–1429. 51 indexed citations
10.
Torimoto, Yoshihiro, David M. Rothstein, Nam H. Dang, S F Schlossman, & C Morimoto. (1992). CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. The Journal of Immunology. 148(2). 388–396. 65 indexed citations
11.
Morimoto, C, Yoshihiro Torimoto, Gene Levinson, et al.. (1990). 1F7, A novel cell surface molecule, involved in helper function of CD4 cells. The Journal of Immunology. 144(5). 2027–2027. 168 indexed citations
12.
Matsuyama, Tomohiko, Akira Yamada, Jonathan Kay, et al.. (1989). Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.. The Journal of Experimental Medicine. 170(4). 1133–1148. 265 indexed citations
13.
Scott, Charles F., Gordon D. McIntyre, JM Lambert, et al.. (1989). Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.. The Journal of Immunology. 142(11). 4105–4112. 30 indexed citations
14.
Takeuchi, Tsutomu, S F Schlossman, & C Morimoto. (1987). The T4 molecule differentially regulating the activation of subpopulations of T4+ cells.. The Journal of Immunology. 139(3). 665–671. 26 indexed citations
15.
Morimoto, C, Yasuhiko Masuho, Yves Borel, A D Steinberg, & S F Schlossman. (1983). Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate.. The Journal of Immunology. 131(4). 1762–1764. 11 indexed citations
16.
Morimoto, C, Ellis L. Reinherz, Robert F. Todd, J A Distaso, & S F Schlossman. (1983). Generation of antigen-specific suppressor cells in vitro in man.. The Journal of Immunology. 131(3). 1209–1213. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026